I am absolutely not against OTCs / ways to onboard partners while engineering buying pressure, but I honestly feel the additional WL is totally counter-productive to the whole tokenomics, you can find my reasoning here: PIP-XX: Whitelisting process for tokenomics emissions - #2 by Figue
Also a bit at a loss on who and how will we find OTC partners.